IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Boxer Capital, LLC

Q3 2018 Holdings

Filed 2018-11-14 | 24 holdings | $109.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beigene LTD(ONC)SPONSORED ADR07725L102$108.5M630,00099.3%
Solid Biosciences IncCOM83422E105$136.0K2,881,6000.1%
PTC Therapeutics Inc(PTCT)COM69366J200$101.3K2,155,0000.1%
Wave Life Sciences LTD(WVE)SHSY95308105$79.5K1,590,6000.1%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$73.7K1,565,5600.1%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$61.0K1,375,0000.1%
Odonate Therapeutics IncCOM676079106$54.9K2,826,9380.1%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$48.4K1,966,0510.0%
Medicines CoCOM584688105$41.9K1,400,0000.0%
DBV Technologies S ASPONSORED ADR23306J101$33.7K1,500,0000.0%
Reata Pharmaceuticals Inc(RETAEUR)CL A75615P103$32.7K400,0000.0%
Kiniksa Pharmaceuticals LTDCOM CL AG5269C101$29.9K1,172,7000.0%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$23.2K2,094,0000.0%
Amarin Corp PLCSPONS ADR NEW023111206$21.2K1,300,0000.0%
Kura Oncology Inc(KURA)COM50127T109$14.8K844,7890.0%
MEI Pharma IncCOM NEW55279B202$12.6K2,913,0910.0%
Rigel Pharmaceuticals Inc(RIGLUSD)COM NEW766559603$7.5K2,321,9000.0%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$4.4K200,0000.0%
Sunesis Pharmaceuticals IncCOM PAR867328700$4.3K2,125,0000.0%
Regulus Therapeutics IncCOM75915K101$4.0K1,697,8020.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$4.0K300,0000.0%
Bellerophon Therapeutics Inc(BLPHEUR)COM078771102$1.6K1,482,1430.0%
Novus Therapeutics IncCOM67011N105$1.5K324,3830.0%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$808100,0000.0%